On 22 September 2025 , the Medical Device Authority (MDA) led a key stakeholder engagement session with the Association of Malaysian Medical Industries (AMMI) in Penang , held at the Iconic Marjorie Hotel. The session, attended by 51 industry participants, focused on strategic discussions regarding regulatory sandboxes for high-tech medical devices, particularly AI-enabled medical devices, and the Medical Device Single Audit Program (MDSAP). These focus areas reflect MDA’s

Indonesia continues strengthening its regulatory landscape with the release of the Regulation of the Minister of Health (Permenkes) No. 11/2025 , issued on 12 November 2025. This regulation introduces updated Business and Product Service Standards for risk-based licensing in the health sub-sector, marking an important step in enhancing service quality, safety, and transparency across the country’s health ecosystem. This new framework aligns with Indonesia’s national effort t

Australia’s Therapeutic Goods Administration (TGA) has introduced major regulatory changes aimed at improving patient safety and reinforcing the traceability of medical devices nationwide. These new requirements, taking effect from 21 March 2026, represent a significant shift in how hospitals, manufacturers, and distributors manage device safety and post-market monitoring. Mandatory Reporting of Device-Related Injuries Under the new regulations, all hospitals in Australia

In the ever-evolving world of medical device regulation, staying ahead of the curve is crucial, especially when entering rapidly growing markets like Malaysia. The newly released Second Edition of MDA/GD/0070 from Malaysia’s Medical Device Authority (MDA) brings clarity and structure to the registration process, especially for manufacturers and authorised representatives who opt for conformity assessment by way of the verification route. Here’s what you need to know and how t

In recent years, the field of regenerative medicine has garnered significant attention worldwide for its potential to revolutionise healthcare by repairing or replacing damaged tissues and organs. Taiwan, with its robust healthcare system and flourishing biomedical sector, is taking proactive steps to enhance its regulatory framework in this innovative field. Understanding the Dual-Track Framework Taiwan's dual-track framework is designed to balance both regulatory oversight

31 October 2025 – Cyberjaya, Malaysia The Medical Device Authority (MDA), under the Ministry of Health (MOH), has issued a media statement to reinforce regulatory control and monitoring of influenza test kits currently available in the Malaysian market. The announcement clarifies that all influenza test kits are classified as In Vitro Diagnostic (IVD) Medical Devices intended strictly for use by trained healthcare professionals. This means these test kits are not approved for

China’s National Medical Products Administration (NMPA) released two draft announcements for public consultation on September 25, 2025 , outlining plans to expand the Unique Device Identification (UDI) system to nearly all classes of medical devices. This proposed expansion marks a significant step in China’s ongoing effort to enhance post-market surveillance, traceability, and regulatory transparency within the medical device sector. Strengthening Device Traceability and Pa

In a move to further strengthen Singapore’s position as a regional hub for medical technology innovation, the Health Sciences Authority (HSA) and the Singapore Manufacturing Federation – Medical Technology Industry Group (SMF MTIG) have launched a new collaborative initiative aimed at supporting medical technology (MedTech) companies with early regulatory guidance and market access readiness. Announced on 2 October 2025 , this partnership builds on Singapore’s broader strat

The Medical Device Authority (MDA) of Malaysia has released the first edition draft guidance document titled “𝘈𝘱𝘱𝘭𝘪𝘤𝘢𝘵𝘪𝘰𝘯 𝘧𝘰𝘳 𝘊𝘰𝘯𝘧𝘪𝘳𝘮𝘢𝘵𝘪𝘰𝘯 𝘚𝘵𝘢𝘵𝘶𝘴 𝘰𝘧 𝘖𝘳𝘱𝘩𝘢𝘯𝘦𝘥 𝘔𝘦𝘥𝘪𝘤𝘢𝘭 𝘋𝘦𝘷𝘪𝘤𝘦”. It is inviting industry stakeholders to provide feedback. This document is a significant step toward managing legacy medical devices that remain in healthcare facilities without active manufacturer or Authorised Representative (AR) oversight, ensur

The Philippine medical device market has opened a crucial window of opportunity for manufacturers preparing their market entry or renewals. On September 5, 2025 , the Philippines Food and Drug Administration (FDA) issued Department Circular No. 2025-0382, announcing the extension of the temporary suspension on medical device registration fees. This follows the initial suspension granted earlier in the year and underscores the agency’s continued commitment to balancing regu

India’s medical device sector is undergoing a significant transformation as the government intensifies efforts to harmonize local...

Indonesia has unveiled an ambitious, multi-decade roadmap to transform its domestic medical device landscape, aiming for full...